Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Angiotensin-converting enzymes in acute respiratory distress syndrome.

Literature DB >> 30927030

Angiotensin-converting enzymes in acute respiratory distress syndrome.

Filippo Annoni¹, Diego Orbegozo¹, Lokmane Rahmania¹, Mariam Irazabal¹, Manuel Mendoza¹, Daniel De Backer¹, Fabio Silvio Taccone¹, Jacques Creteur¹, Jean-Louis Vincent².

Abstract

Entities: Disease

Year: 2019 PMID： 30927030 DOI： 10.1007/s00134-019-05600-6

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

5 in total

1. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.

Authors: Roelie M Wösten-van Asperen; René Lutter; Patricia A Specht; Gert N Moll; Job B van Woensel; Chris M van der Loos; Harry van Goor; Jelena Kamilic; Sandrine Florquin; Albert P Bos
Journal: J Pathol Date: 2011-10-18 Impact factor: 7.996

Review 2. The pulmonary renin-angiotensin system.

Authors: Richard P Marshall
Journal: Curr Pharm Des Date: 2003 Impact factor: 3.116

3. Acute respiratory distress syndrome: the Berlin Definition.

Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal: JAMA Date: 2012-06-20 Impact factor: 56.272

4. Angiotensin-converting enzyme 2 protects from severe acute lung failure.

Authors: Yumiko Imai; Keiji Kuba; Shuan Rao; Yi Huan; Feng Guo; Bin Guan; Peng Yang; Renu Sarao; Teiji Wada; Howard Leong-Poi; Michael A Crackower; Akiyoshi Fukamizu; Chi-Chung Hui; Lutz Hein; Stefan Uhlig; Arthur S Slutsky; Chengyu Jiang; Josef M Penninger
Journal: Nature Date: 2005-07-07 Impact factor: 49.962

5. Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.

Authors: Vanessa Zambelli; Giacomo Bellani; Roberto Borsa; Federico Pozzi; Alice Grassi; Margherita Scanziani; Vittoria Castiglioni; Serge Masson; Alessandra Decio; John G Laffey; Roberto Latini; Antonio Pesenti
Journal: Intensive Care Med Exp Date: 2015-02-27

5 in total

1. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.

Authors: Juan Gómez; Guillermo M Albaiceta; Marta García-Clemente; Carlos López-Larrea; Laura Amado-Rodríguez; Inés Lopez-Alonso; Tamara Hermida; Ana I Enriquez; Pablo Herrero; Santiago Melón; Marta E Alvarez-Argüelles; José A Boga; Susana Rojo-Alba; Elías Cuesta-Llavona; Victoria Alvarez; Rebeca Lorca; Eliecer Coto
Journal: Gene Date: 2020-08-31 Impact factor: 3.688

Review 5. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Authors: A Aleksova; F Ferro; G Gagno; C Cappelletto; D Santon; M Rossi; G Ippolito; A Zumla; A P Beltrami; G Sinagra
Journal: J Intern Med Date: 2020-06-08 Impact factor: 13.068

5 in total

Angiotensin-converting enzymes in acute respiratory distress syndrome.

1. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist.

Review 2. The pulmonary renin-angiotensin system.

3. Acute respiratory distress syndrome: the Berlin Definition.

4. Angiotensin-converting enzyme 2 protects from severe acute lung failure.

5. Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.

1. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.

2. Cyclic ⁶⁸Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2.

Review 3. The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome.

4. The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study.

Review 5. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?